logo
Sign in

RSLS Stock Price, Chart, Stats & News

ReShape Lifesciences Inc.
Save
2.34M
Market cap
Current P/E
Forward P/E

RSLS chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
68.43%
Operating margin
-3259.05%
Pretax margin
-2890.40%
Net margin
-2897.28%
Effective tax rate
-0.24%
ROA
-142.57%
ROE
-277.53%
D/E
0.01x
Interest coverage ratio
-61.80x

RSLS valuation

P/E
P/S
7.31x
P/B
0.26x
P/CF
-0.12x
P/FCF
-0.29x
P/OCF
-0.12x
PEG
-0.00x
EV multiple
-0.59x

About

Founded in 2002 and based in San Clemente, California, ReShape Lifesciences Inc. operates as a medical device company dedicated to addressing obesity and metabolic diseases. The company's market extends throughout the United States, Australia, Europe, and globally. Its diverse product lineup features the Lap-Band System, a minimally invasive, long-term solution for severe obesity that offers an alternative to more extensive surgical interventions like gastric bypass or sleeve gastrectomy.

Similar securities

Based on sector and market capitalization

Report issue